# CSL Behring UK Limited — UK public sector contract awards

> A prime supplier profile built from sourced government contract award notices.

## Key facts

- Awards: 8
- Known award value: £905,870,206
- First award: 15 February 2019
- Latest award: 12 June 2026

## Top public sector buyers

- [NHS England](/buyers/nhs-england/contract-awards) — 3 awards
- [Calderdale and Huddersfield Solutions](/buyers/calderdale-and-huddersfield-solutions/contract-awards) — 1 awards
- [Hull University Teaching Hospitals NHS Trust](/buyers/hull-university-teaching-hospitals-nhs-trust/contract-awards) — 1 awards
- [Norfolk and Norwich University Hospitals NHS Foundation Trust](/buyers/norfolk-and-norwich-university-hospitals-nhs-foundation-trust/contract-awards) — 1 awards
- [The Christie NHS Foundation Trust](/buyers/the-christie-nhs-foundation-trust/contract-awards) — 1 awards

## Contract awards

### [NHS Framework Agreement for Branded Medicines - Proprietary Category Tender](/contracts/ocds-b5fd17-1063d704-a8da-4ec0-b11c-5b9fec849d60)

NHS England · £1,241,520,444 · 24 March 2025 · awarded

### [CSL Behring - Blood Disorder Treatment products \(inc Haemophilia A & B\)](/contracts/ocds-b5fd17-febd0792-7c78-4784-93a3-40afdb13f4a0)

Norfolk and Norwich University Hospitals NHS Foundation Trust · £416,032 · 1 January 2025 · awarded

### [NHS Framework Agreement for Human Albumin & Normal and Anti-D Immunoglobulin](/contracts/ocds-b5fd17-63eefe2c-af75-4320-8392-e35c49eff8b9)

NHS England · £905,187,090 · 19 December 2024 · awarded

### [CRH standing order for 1500IU anti D Immunoglobulin-Rhophyl](/contracts/ocds-b5fd17-f5d26917-5137-416a-be5a-1d639e857250)

Calderdale and Huddersfield Solutions · £55,376 · 19 November 2021 · awarded

### [NATIONAL FRAMEWORK AGREEMENT FOR THE SUPPLY OF HUMAN NORMAL IMMUNOGLOBULIN AND ANTI-D IMMUNOGLOBULIN](/contracts/ocds-b5fd17-622c87fd-ec26-418a-97c2-4fe18bb068d1)

HULL UNIVERSITY TEACHING HOSPITALS NHS TRUST · £188,608 · 28 June 2021 · awarded

### [Human Albumin and Anti D](/contracts/ocds-b5fd17-8e7f0a53-c557-43e3-a364-5b200b0d0251)

WALSALL HEALTHCARE NHS TRUST · £11,100 · 1 March 2021 · awarded

### [NHS Framework Agreement for the supply of Recombinant Factor IX products for the treatment of Haemophilia B](/contracts/ocds-b5fd17-e9aa86d5-034f-4ac0-957f-a4479ae257f5)

NHS England · £192,000,000 · 15 February 2019 · awarded